Silica nanoparticles as drug delivery system for immunomodulator GMDP:
The development of nanosystems for topical drug delivery to target cells is a promising tool to improve the drug therapeutic index. Transport systems can be designed to control the dispatch of the loaded drug to target areas increasing its its local concentration and bioavailability, while prolongin...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
American Society of Mechanical Engineers
2012
|
| Schriftenreihe: | Biomedical & nanomedical technologies
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | The development of nanosystems for topical drug delivery to target cells is a promising tool to improve the drug therapeutic index. Transport systems can be designed to control the dispatch of the loaded drug to target areas increasing its its local concentration and bioavailability, while prolonging its retention, half-life and effectiveness. Therefore, such "smart" nanodevices are able to change radically the practice of therapy for a variety of diseases and disorders. The purpose of this book is to present the recent research development of nanoparticulate delivery systems for immune modulating agent, glucosaminyl muramyldipeptides (N-acetylglucosaminyl-Nacetylmuramyl--L-alanyl-D-isoglutamine) or GMDP, which is the main component of bacterial wall with known target of action through NOD2 receptors, with an overlook to their applications for treatment of endometriosis, which often results in infertility. Silica-based nanoparticles have generated a significant amount of interest because of their inherent properties |
| Beschreibung: | System requirements: Adobe Acrobat Reader. - Mode of access: World Wide Web |
| Beschreibung: | 1 Online-Ressource (x, 69 Seiten) illustrations |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046643983 | ||
| 003 | DE-604 | ||
| 005 | 20201021 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 200327s2012 |||| o||u| ||||||eng d | ||
| 024 | 7 | |a 10.1115/1.860021 |2 doi | |
| 035 | |a (ZDB-240-ASM)1011151860021 | ||
| 035 | |a (OCoLC)1148122098 | ||
| 035 | |a (DE-599)BVBBV046643983 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-83 | ||
| 084 | |a VE 9850 |0 (DE-625)147163:253 |2 rvk | ||
| 100 | 1 | |a Parfenyuk, E. V. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Silica nanoparticles as drug delivery system for immunomodulator GMDP |c E.V. Parfenyuk, N.A. Alyoshina, Yu.S. Antsiferova, N.Yu. Sotnikova |
| 264 | 1 | |a New York |b American Society of Mechanical Engineers |c 2012 | |
| 300 | |a 1 Online-Ressource (x, 69 Seiten) |b illustrations | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Biomedical & nanomedical technologies | |
| 500 | |a System requirements: Adobe Acrobat Reader. - Mode of access: World Wide Web | ||
| 505 | 8 | |a Includes bibliographical references (pages [59]-69) | |
| 505 | 8 | |a Drug delivery nanosystems as a promising area of modern chemistry and medicine. Silica nanoparticles as potential drug carriers -- Principles and criteria of vibration isolation -- Syntheses of mesoporous silica materials -- Realization of elasticity and damping in vibration isolators -- Characterization of silica materials as potential carriers for GMDP -- Passive vibration isolation means -- Interaction of silica nanoparticles with immune system cells -- Peritoneal macrophages of women with endometriosis as a possible target for immunomodulatory drugs -- Effectiveness of different types of silica nanoparticles as drug carriers for topical delivery of GMDP into peritoneal macrophages of women with endometriosis | |
| 520 | |a The development of nanosystems for topical drug delivery to target cells is a promising tool to improve the drug therapeutic index. Transport systems can be designed to control the dispatch of the loaded drug to target areas increasing its its local concentration and bioavailability, while prolonging its retention, half-life and effectiveness. Therefore, such "smart" nanodevices are able to change radically the practice of therapy for a variety of diseases and disorders. The purpose of this book is to present the recent research development of nanoparticulate delivery systems for immune modulating agent, glucosaminyl muramyldipeptides (N-acetylglucosaminyl-Nacetylmuramyl--L-alanyl-D-isoglutamine) or GMDP, which is the main component of bacterial wall with known target of action through NOD2 receptors, with an overlook to their applications for treatment of endometriosis, which often results in infertility. Silica-based nanoparticles have generated a significant amount of interest because of their inherent properties | ||
| 650 | 4 | |a Drug delivery systems | |
| 650 | 4 | |a Nanosilicon | |
| 650 | 4 | |a Immunological adjuvants | |
| 650 | 4 | |a Nanomedicine | |
| 650 | 4 | |a Nanoparticles | |
| 650 | 4 | |a Endometriosis / Treatment | |
| 650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Nanopartikel |0 (DE-588)4333369-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Siliciumdioxid |0 (DE-588)4077447-8 |2 gnd |9 rswk-swf |
| 653 | |a Electronic books | ||
| 689 | 0 | 0 | |a Nanopartikel |0 (DE-588)4333369-2 |D s |
| 689 | 0 | 1 | |a Siliciumdioxid |0 (DE-588)4077447-8 |D s |
| 689 | 0 | 2 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Alyoshina, N. A. |e Sonstige |4 oth | |
| 700 | 1 | |a Ant︠s︡iferova, Yu. S. |e Sonstige |4 oth | |
| 700 | 1 | |a Sotnikova, N. I︠U︡. |e Sonstige |4 oth | |
| 710 | 2 | |a American Society of Mechanical Engineers |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u https://asmedigitalcollection.asme.org/ebooks/book/109/Silica-Nanoparticles-as-Drug-Delivery-System-for |x Verlag |3 Volltext |
| 912 | |a ZDB-240-ASM | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032055293 | ||
Datensatz im Suchindex
| _version_ | 1804181340343500800 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Parfenyuk, E. V. |
| author_facet | Parfenyuk, E. V. |
| author_role | aut |
| author_sort | Parfenyuk, E. V. |
| author_variant | e v p ev evp |
| building | Verbundindex |
| bvnumber | BV046643983 |
| classification_rvk | VE 9850 |
| collection | ZDB-240-ASM |
| contents | Includes bibliographical references (pages [59]-69) Drug delivery nanosystems as a promising area of modern chemistry and medicine. Silica nanoparticles as potential drug carriers -- Principles and criteria of vibration isolation -- Syntheses of mesoporous silica materials -- Realization of elasticity and damping in vibration isolators -- Characterization of silica materials as potential carriers for GMDP -- Passive vibration isolation means -- Interaction of silica nanoparticles with immune system cells -- Peritoneal macrophages of women with endometriosis as a possible target for immunomodulatory drugs -- Effectiveness of different types of silica nanoparticles as drug carriers for topical delivery of GMDP into peritoneal macrophages of women with endometriosis |
| ctrlnum | (ZDB-240-ASM)1011151860021 (OCoLC)1148122098 (DE-599)BVBBV046643983 |
| discipline | Chemie / Pharmazie |
| discipline_str_mv | Chemie / Pharmazie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03964nmm a2200577zc 4500</leader><controlfield tag="001">BV046643983</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20201021 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">200327s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1115/1.860021</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-240-ASM)1011151860021</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1148122098</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046643983</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-83</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VE 9850</subfield><subfield code="0">(DE-625)147163:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Parfenyuk, E. V.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Silica nanoparticles as drug delivery system for immunomodulator GMDP</subfield><subfield code="c">E.V. Parfenyuk, N.A. Alyoshina, Yu.S. Antsiferova, N.Yu. Sotnikova</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">American Society of Mechanical Engineers</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 69 Seiten)</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Biomedical & nanomedical technologies</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">System requirements: Adobe Acrobat Reader. - Mode of access: World Wide Web</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references (pages [59]-69)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Drug delivery nanosystems as a promising area of modern chemistry and medicine. Silica nanoparticles as potential drug carriers -- Principles and criteria of vibration isolation -- Syntheses of mesoporous silica materials -- Realization of elasticity and damping in vibration isolators -- Characterization of silica materials as potential carriers for GMDP -- Passive vibration isolation means -- Interaction of silica nanoparticles with immune system cells -- Peritoneal macrophages of women with endometriosis as a possible target for immunomodulatory drugs -- Effectiveness of different types of silica nanoparticles as drug carriers for topical delivery of GMDP into peritoneal macrophages of women with endometriosis</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The development of nanosystems for topical drug delivery to target cells is a promising tool to improve the drug therapeutic index. Transport systems can be designed to control the dispatch of the loaded drug to target areas increasing its its local concentration and bioavailability, while prolonging its retention, half-life and effectiveness. Therefore, such "smart" nanodevices are able to change radically the practice of therapy for a variety of diseases and disorders. The purpose of this book is to present the recent research development of nanoparticulate delivery systems for immune modulating agent, glucosaminyl muramyldipeptides (N-acetylglucosaminyl-Nacetylmuramyl--L-alanyl-D-isoglutamine) or GMDP, which is the main component of bacterial wall with known target of action through NOD2 receptors, with an overlook to their applications for treatment of endometriosis, which often results in infertility. Silica-based nanoparticles have generated a significant amount of interest because of their inherent properties</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug delivery systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanosilicon</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunological adjuvants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endometriosis / Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nanopartikel</subfield><subfield code="0">(DE-588)4333369-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Siliciumdioxid</subfield><subfield code="0">(DE-588)4077447-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Nanopartikel</subfield><subfield code="0">(DE-588)4333369-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Siliciumdioxid</subfield><subfield code="0">(DE-588)4077447-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alyoshina, N. A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ant︠s︡iferova, Yu. S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sotnikova, N. I︠U︡.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">American Society of Mechanical Engineers</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://asmedigitalcollection.asme.org/ebooks/book/109/Silica-Nanoparticles-as-Drug-Delivery-System-for</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-240-ASM</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032055293</subfield></datafield></record></collection> |
| id | DE-604.BV046643983 |
| illustrated | Illustrated |
| index_date | 2024-07-03T14:14:55Z |
| indexdate | 2024-07-10T08:50:06Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032055293 |
| oclc_num | 1148122098 |
| open_access_boolean | |
| owner | DE-83 |
| owner_facet | DE-83 |
| physical | 1 Online-Ressource (x, 69 Seiten) illustrations |
| psigel | ZDB-240-ASM |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | American Society of Mechanical Engineers |
| record_format | marc |
| series2 | Biomedical & nanomedical technologies |
| spelling | Parfenyuk, E. V. Verfasser aut Silica nanoparticles as drug delivery system for immunomodulator GMDP E.V. Parfenyuk, N.A. Alyoshina, Yu.S. Antsiferova, N.Yu. Sotnikova New York American Society of Mechanical Engineers 2012 1 Online-Ressource (x, 69 Seiten) illustrations txt rdacontent c rdamedia cr rdacarrier Biomedical & nanomedical technologies System requirements: Adobe Acrobat Reader. - Mode of access: World Wide Web Includes bibliographical references (pages [59]-69) Drug delivery nanosystems as a promising area of modern chemistry and medicine. Silica nanoparticles as potential drug carriers -- Principles and criteria of vibration isolation -- Syntheses of mesoporous silica materials -- Realization of elasticity and damping in vibration isolators -- Characterization of silica materials as potential carriers for GMDP -- Passive vibration isolation means -- Interaction of silica nanoparticles with immune system cells -- Peritoneal macrophages of women with endometriosis as a possible target for immunomodulatory drugs -- Effectiveness of different types of silica nanoparticles as drug carriers for topical delivery of GMDP into peritoneal macrophages of women with endometriosis The development of nanosystems for topical drug delivery to target cells is a promising tool to improve the drug therapeutic index. Transport systems can be designed to control the dispatch of the loaded drug to target areas increasing its its local concentration and bioavailability, while prolonging its retention, half-life and effectiveness. Therefore, such "smart" nanodevices are able to change radically the practice of therapy for a variety of diseases and disorders. The purpose of this book is to present the recent research development of nanoparticulate delivery systems for immune modulating agent, glucosaminyl muramyldipeptides (N-acetylglucosaminyl-Nacetylmuramyl--L-alanyl-D-isoglutamine) or GMDP, which is the main component of bacterial wall with known target of action through NOD2 receptors, with an overlook to their applications for treatment of endometriosis, which often results in infertility. Silica-based nanoparticles have generated a significant amount of interest because of their inherent properties Drug delivery systems Nanosilicon Immunological adjuvants Nanomedicine Nanoparticles Endometriosis / Treatment Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf Nanopartikel (DE-588)4333369-2 gnd rswk-swf Siliciumdioxid (DE-588)4077447-8 gnd rswk-swf Electronic books Nanopartikel (DE-588)4333369-2 s Siliciumdioxid (DE-588)4077447-8 s Wirkstofffreisetzung (DE-588)4190018-2 s DE-604 Alyoshina, N. A. Sonstige oth Ant︠s︡iferova, Yu. S. Sonstige oth Sotnikova, N. I︠U︡. Sonstige oth American Society of Mechanical Engineers Sonstige oth https://asmedigitalcollection.asme.org/ebooks/book/109/Silica-Nanoparticles-as-Drug-Delivery-System-for Verlag Volltext |
| spellingShingle | Parfenyuk, E. V. Silica nanoparticles as drug delivery system for immunomodulator GMDP Includes bibliographical references (pages [59]-69) Drug delivery nanosystems as a promising area of modern chemistry and medicine. Silica nanoparticles as potential drug carriers -- Principles and criteria of vibration isolation -- Syntheses of mesoporous silica materials -- Realization of elasticity and damping in vibration isolators -- Characterization of silica materials as potential carriers for GMDP -- Passive vibration isolation means -- Interaction of silica nanoparticles with immune system cells -- Peritoneal macrophages of women with endometriosis as a possible target for immunomodulatory drugs -- Effectiveness of different types of silica nanoparticles as drug carriers for topical delivery of GMDP into peritoneal macrophages of women with endometriosis Drug delivery systems Nanosilicon Immunological adjuvants Nanomedicine Nanoparticles Endometriosis / Treatment Wirkstofffreisetzung (DE-588)4190018-2 gnd Nanopartikel (DE-588)4333369-2 gnd Siliciumdioxid (DE-588)4077447-8 gnd |
| subject_GND | (DE-588)4190018-2 (DE-588)4333369-2 (DE-588)4077447-8 |
| title | Silica nanoparticles as drug delivery system for immunomodulator GMDP |
| title_auth | Silica nanoparticles as drug delivery system for immunomodulator GMDP |
| title_exact_search | Silica nanoparticles as drug delivery system for immunomodulator GMDP |
| title_exact_search_txtP | Silica nanoparticles as drug delivery system for immunomodulator GMDP |
| title_full | Silica nanoparticles as drug delivery system for immunomodulator GMDP E.V. Parfenyuk, N.A. Alyoshina, Yu.S. Antsiferova, N.Yu. Sotnikova |
| title_fullStr | Silica nanoparticles as drug delivery system for immunomodulator GMDP E.V. Parfenyuk, N.A. Alyoshina, Yu.S. Antsiferova, N.Yu. Sotnikova |
| title_full_unstemmed | Silica nanoparticles as drug delivery system for immunomodulator GMDP E.V. Parfenyuk, N.A. Alyoshina, Yu.S. Antsiferova, N.Yu. Sotnikova |
| title_short | Silica nanoparticles as drug delivery system for immunomodulator GMDP |
| title_sort | silica nanoparticles as drug delivery system for immunomodulator gmdp |
| topic | Drug delivery systems Nanosilicon Immunological adjuvants Nanomedicine Nanoparticles Endometriosis / Treatment Wirkstofffreisetzung (DE-588)4190018-2 gnd Nanopartikel (DE-588)4333369-2 gnd Siliciumdioxid (DE-588)4077447-8 gnd |
| topic_facet | Drug delivery systems Nanosilicon Immunological adjuvants Nanomedicine Nanoparticles Endometriosis / Treatment Wirkstofffreisetzung Nanopartikel Siliciumdioxid |
| url | https://asmedigitalcollection.asme.org/ebooks/book/109/Silica-Nanoparticles-as-Drug-Delivery-System-for |
| work_keys_str_mv | AT parfenyukev silicananoparticlesasdrugdeliverysystemforimmunomodulatorgmdp AT alyoshinana silicananoparticlesasdrugdeliverysystemforimmunomodulatorgmdp AT antsiferovayus silicananoparticlesasdrugdeliverysystemforimmunomodulatorgmdp AT sotnikovaniu silicananoparticlesasdrugdeliverysystemforimmunomodulatorgmdp AT americansocietyofmechanicalengineers silicananoparticlesasdrugdeliverysystemforimmunomodulatorgmdp |